Xstrahl

The Xstrahl team is showcasing Radiant™ Aura at the ASMS meeting at The Loews Sapphire Falls in Orlando. Stop by our booth to learn more about our non-surgical treatment options.

Listen to the Out of the Gray (Gy) podcast to hear from Dr. Richard Shaffer, Radiation Oncologist, Xstrahl's Medical Director, and Founder of the International Organisation for Radiotherapy for Benign Conditions (IORBC).

The episode - An International Perspective: Radiotherapy for Benign Conditions. Listen on Apple Podcasts or Spotify: https://open.spotify.com/episode/2eNLl5JT1e5C1dvcix3UQ3?si=81f2eb8f66e7462d

Hear from Professor Brian Marples of the University of Rochester, Department of Radiation Oncology, as he describes the range of applications covering the effect of radiation in normal tissue and how this can be assessed and mitigated. Prof. Marples also highlights the use of radiotherapy in non-cancerous applications, particularly the use of low-dose RT: https://xstrahl.com/preclinical-igrt-webcast-marples/

Xstrahl is pleased to showcase Radiant™ Aura at this year’s ASMS meeting at The Loews Sapphire Falls in Orlando. Stop by our booth to learn more about Radiant Aura, our dual modality system that provides non-surgical treatment options: https://xstrahl.com/asms2024_news

Xstrahl in Action: Definitive Superficial Radiotherapy for Challenging Skin Cancers

In this case series of experiences and learnings, RT was delivered using the Xstrahl 200 X-ray system, which delivers both superficial treatments and treatments at depth by combining the capability of orthovoltage X-ray systems with the traditional ease-of-use of superficial radiation therapy: https://xstrahl.com/definitive-srt-xia/

Xstrahl will be at DEGRO Kongress 2024 in Kassel, Germany. Visit with our team to hear more about our superficial and orthovoltage radiotherapy solutions and the latest in radiation research: https://xstrahl.com/degro2024_news

Did you miss our webcast with Dr. Jason Beckta? See the Q&A session in its entirety here! The Radiation Oncologist, Assistant Professor at the University of Vermont, and Medical Director at Rutland Regional Medical Center answered questions about for arthritis and spoke about the beneficial health effects he’s seen in the delivery of LDRT for arthritis patients in his clinical practice.

https://xstrahl.com/beckta-ldrt-arthritis-webcast/

Millions of people are diagnosed with non-melanoma skin cancer (NMSC) worldwide each year. Non-invasive radiotherapy techniques like electronic brachytherapy and superficial radiation therapy are powerful tools for treating basal cell carcinoma and squamous cell carcinoma, among other diseases.

Xstrahl is participating in several exciting upcoming events. In June, our team will be at DEGRO 2024 in Germany, the 2024 ASMS Annual Meeting in Florida, and the ARR 2024 Conference in the UK.

may be over, but expanding treatment options for all who suffer from remains our top priority. When it comes to , we are proud to offer innovative treatment options with .

Curative treatment of is broadly divided into surgical excision (which accounts for most cases), radiation therapy, and other treatments. See how radiation therapy compares to other treatment options: https://xstrahl.com/non-melanoma-skin-cancer-nmsc/

Lesions on the skin of the lower extremities of older patients require extra caution. In case study number four, we can see how electronic brachytherapy with Xstrahl Radiant helped a 75-year-old female patient with a right lower extremity lesion complicated by diabetes and hypertension: https://xstrahl.com/bcc-scc-treatment/

Case study number three also centered on a basal cell carcinoma - this time, on the eyelid. This patient received electronic brachytherapy with Xstrahl Radiant treatment and, at the one-year follow-up, the patient showed an excellent cosmetic outcome: https://xstrahl.com/bcc-scc-treatment/

In our second case study, see how DermRay treated a patient with a basal cell carcinoma (BCC) of the nasal tip. At his six-month follow-up visit, there is virtually no evidence of the lesion with an excellent cosmetic outcome: https://xstrahl.com/bcc-scc-treatment/

Xstrahl will highlight Radiant Aura at the 2024 Congress of Clinical Dermatology, from May 30 to June 2, in Amelia Island, FL. Radiant Aura is the painless non-surgical skin cancer treatment alternative. Visit us to learn more about our dual modality treatment solution for dermatologists.

http://www.xstrahl.com/congress_clinical_derm_news

A 90-year-old female patient presented with a three-centimeter squamous cell carcinoma (SCC). The patient underwent electronic brachytherapy treatment schedule with Xstrahl Radiant. See the dramatic before and after photos:

https://xstrahl.com/bcc-scc-treatment/

One of the best ways to demonstrate the benefits of radiation therapy is through the stories of patients who have benefitted from its use.

To close out , we’ll be sharing four case studies that highlight the effectiveness of Xstrahl’s Radiant system at delivering electronic brachytherapy and superficial radiation therapy. Stay tuned and read more here: https://xstrahl.com/bcc-scc-treatment/

Are you at ? Meet the Xstrahl team and find out how you can implement cost-effective radiation treatment in your practice quickly and easily.

https://xstrahl.com/esvonc-2024/

Join today! At 7:30pm EST/6:30pm CT, Dr. Steven Davis will talk about his use of superficial radiation therapy to treat keloids post-operatively. Learn more and register here: https://xstrahl.com/superficial-rt-webcast-davis/

Join Dr. Steven Davis, medical director of The Dermatology & Laser Center of San Antonio, tomorrow May 21 at 7:30 pm EST/ 6:30pm CT to learn more about his use of superficial radiation therapy to treat keloids post-operatively. Learn more and register here:

Superficial Radiation Therapy Post-Op for Keloids: Protocols, Techniques, and Outcomes - Xstrahl Superficial Radiation Therapy Post-Op for Keloids: Protocols, Techniques, and Outcomes Interactive Webcast on Tuesday, May 21 7:30 PM EDT / 6:30 PM CDT Join Xstrahl and Dr. Steven Davis, Medical Director of The Dermatology & Laser Center of San Antonio, for this webinar to learn about using superfic...

The 2024 ESVONC Congress will be held in Bucharest, Roumania May 22nd - 26th. The Xstrahl team looks forward to sharing our overall contributions to the new strides being made in veterinary oncology.

Learn more: https://xstrahl.com/esvonc-2024/

Radiant Aura Q&A: Treatment for skin cancers using SRT is comparable to surgical excision with 90-98% effectiveness. Treatment of keloids, combined with a suitable surgical excision, has a success rate of up to 94%.

How long has X-ray therapy been around? See a breakdown of the history: https://xstrahl.com/history-of-x-rays/

Read about Dr. Sean E. Mazloom, MD, FAAD, from ReJUVA Dermatology, Vein & Skin Cancer Center, Venice, FL and his experience using the RADiant system to treat both squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) in his practice: https://xstrahl.com/office-based-rt_2case_studies/

Radiant Aura is designed for office-based dermatology. Learn more here: https://xstrahl.com/radiation-therapy-is-more-accessible-than-you-think/

Superficial radiation therapy offers non-surgical treatment options to office-based dermatology practices to expand patient care for non-melanoma skin cancers, such as basal cell and squamous cell carcinoma, and to reduce keloid recurrence post-operatively.

Please join Dr. Steven Davis, medical director of The Dermatology & Laser Center of San Antonio, on May 21 at 6:30pm CT to learn more about his use of superficial radiation therapy to treat keloids post-operatively. Learn more and register here:

Superficial Radiation Therapy Post-Op for Keloids: Protocols, Techniques, and Outcomes - Xstrahl Superficial Radiation Therapy Post-Op for Keloids: Protocols, Techniques, and Outcomes Interactive Webcast on Tuesday, May 21 at 6:30 PM CDT Join Xstrahl and Dr. Steven Davis, Medical Director of The Dermatology & Laser Center of San Antonio, for this webinar to learn about using superficial radiati...

Xstrahl is enthusiastic about the great strides being made in the Radiation Oncology space.

Patient care is at the center of our mission. At , we showcased our newest contribution to improved patient care in radiation therapy: internal eye shields.

It is officially ! Xstrahl is committed to expanding care options for patients diagnosed with Skin Cancer.

Xstrahl is showcasing Radiant Aura at . We are excited about all of the possibilities that come with advancing dual modality radiotherapy treatment: https://xstrahl.com/norcal2024_news/

The theme for is Radiation Oncology: Bridging the Care Gap. We’ll be showcasing our internal eye shields for patient-specific use during radiation therapy.

Xstrahl is pleased to have worked with Hull University Teaching Hospitals NHS Trust and the result is an affordable and effective internal eye shield for patient-specific use during radiation therapy.

Learn more about how we plan to spotlight superficial and orthovoltage radiotherapy solutions for skin cancer and benign conditions at ESTRO 2024 here: https://xstrahl.com/estro2024-news